ADENOCARCINOMA GASTROESOPHAGEAL JUNCTION

Clinical trials for ADENOCARCINOMA GASTROESOPHAGEAL JUNCTION explained in plain language.

Never miss a new study

Get alerted when new ADENOCARCINOMA GASTROESOPHAGEAL JUNCTION trials appear

Sign up with your email to follow new studies for ADENOCARCINOMA GASTROESOPHAGEAL JUNCTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Double-Punch immunotherapy trial aims to keep stomach cancer at bay after surgery

Disease control Terminated

This study aimed to test whether adding two immunotherapy drugs (domvanalimab and zimberelimab) to standard chemotherapy could better control cancer in people with operable stomach or esophageal cancer. Patients would have received the drug combination for about 4 months before s…

Matched conditions: ADENOCARCINOMA GASTROESOPHAGEAL JUNCTION

Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

ADENOCARCINOMA GASTROESOPHAGEAL JUNCTION

Get alerted when new ADENOCARCINOMA GASTROESOPHAGEAL JUNCTION trials appear

Double-Punch immunotherapy trial aims to keep stomach cancer at bay after surgery